Syndax Pharmaceuticals (SNDX) – Major News
-
Syndax Pharmaceuticals (SNDX) Misses Q4 EPS by 3c
-
Syndax Pharmaceuticals (SNDX) Tops Q3 EPS by 6c
-
Syndax Pharmaceuticals (SNDX) Tops Q2 EPS by 8c
-
Syndax Pharmaceuticals (SNDX) Tops Q1 EPS by 6c
-
Syndax Pharmaceuticals (SNDX) Tops Q4 EPS by 3c
-
Syndax Pharmaceuticals (SNDX) Reports In-Line Q1 EPS
-
Syndax Pharmaceuticals (SNDX) Tops Q4 EPS, Revenue
-
Syndax Pharmaceuticals (SNDX) Misses Q3 EPS by 17c
-
Syndax Pharmaceuticals (SNDX) Tops Q2 EPS by 27c
-
Syndax Pharmaceuticals (SNDX) Tops Q1 EPS by 11c, Revenues Beat
-
Syndax Pharmaceuticals (SNDX) Tops Q4 EPS by 5c
-
Syndax Pharmaceuticals (SNDX) Misses Q3 EPS by 2c
-
Syndax Pharmaceuticals (SNDX) Tops Q2 EPS by 3c
-
Syndax Pharmaceuticals (SNDX) Misses Q1 EPS by 5c
-
Syndax Pharmaceuticals (SNDX) Misses Q4 EPS by 2c
-
Syndax Pharmaceuticals (SNDX) Tops Q3 EPS by 6c
-
Syndax Pharmaceuticals (SNDX) Tops Q1 EPS by 2c
-
Syndax Pharmaceuticals (SNDX) Misses Q4 EPS by 3c; Provides Q1 & FY19 Operating Guidance
-
Syndax Pharmaceuticals (SNDX) Tops Q3 EPS by 8c
-
Syndax Pharmaceuticals (SNDX) Tops Q2 EPS by 13c
-
Syndax Pharmaceuticals (SNDX) Tops Q1 EPS by 17c
-
Syndax Pharmaceuticals (SNDX) Misses Q4 EPS by 2c, Miss on Revenues
-
Syndax Pharmaceuticals (SNDX) Tops Q3 EPS by 12c
-
Syndax Pharmaceuticals (SNDX) Tops Q2 EPS by 13c, Beats on Revenues; Offers FY17 OpEx Guidance
-
Syndax Pharmaceuticals (SNDX) Misses Q1 EPS by 3c
-
UPDATE: Syndax Pharmaceuticals (SNDX) Tops Q4 EPS by 11c; Encore 601 Refractory Melanoma Cohort to Proceed to Second Stage of Phase 2
-
Syndax Pharmaceuticals (SNDX) Misses Q3 EPS by 13c
-
Syndax Pharmaceuticals (SNDX) Reports Q2 Loss of $0.47/Share
-
Syndax Pharmaceuticals (SNDX) IPO Opens Flat
Back to SNDX Stock Lookup